SFEBES2019

    07:30 - 19:00 
    REGISTRATION
    08:30 - 09:00 
    Plenary 4: Society for Endocrinology Transatlantic Medal Lecture
    08:30

    Session starts at 08:30
    How is alkaline phosphatase essential for bone? The Transatlantic stories
    Michael Whyte (St Louis, USA)

    09:00 - 09:30 
    Plenary 5: Society for Endocrinology International Medal Lecture
    09:00

    Session starts at 09:00
    The Melanocortin Microcircuitry and its Role in Energy Homeostasis
    Roger Cone (Ann Arbor, USA)

    09:35 - 10:35 
    Early Careers and Plenary Orals
    09:35

    Session starts at 09:35
    Early Career Prize lecture Clinical

    09:55

    Session starts at 09:35
    Early Career Prize lecture Basic

    10:15

    Session starts at 09:35
    EC1.3
    Urine steroid metabolome analysis allows for metabolic risk stratification in 1309 prospectively recruited patients with benign adrenal tumours and different degrees of cortisol excess
    CET Best Abstract Clinical
    Alessandro Prete (Birmingham, United Kingdom)

    10:25

    Session starts at 09:35
    EC1.4
    Mice harbouring a germline heterozygous AP2S1 mutation, Arg15Leu, are a model for familial hypocalciuric hypercalcaemia type 3 (FHH3)
    CET Best Abstract Basic
    Fadil Hannan (Oxford, United Kingdom)

    10:35 - 11:05 
    TEA & COFFEE
    11:05 - 12:35 
    Symposium 1: Gut hormones physiology pathology and pharamcology
    11:05

    Session starts at 11:05
    Physiology and pharmacology of gut hormones
    Fiona Gribble (Cambridge, UK)

    11:35

    Session starts at 11:05
    Combination of gut hormone therapy
    Tricia Tan (London, UK)

    12:05

    Session starts at 11:05
    Therapeutic landscape
    John Wilding (Liverpool, UK)

    11:05 - 11:35 
    Symposium 2: New insights into PCOS
    Fat, fertility and PCOS
    11:05

    Session starts at 11:05
    Fetal antecedents of PCOS is there a role of AMH
    Jenny Visser (Rotterdam, The Netherlands)

    11:35

    Session starts at 11:05
    PCOS, obesity and energy balance
    Colin Duncan (Edinburgh, UK)

    12:05

    Session starts at 11:05
    Origins of obesity in women with PCOS
    Terhi Piltonen (Oulu, Finland)

    11:05 - 12:35 
    Symposium 3: Phosphate homeostasis physiology pathology and pharmacology
    11:05

    Session starts at 11:05
    Advances in FGF23 Signalling

    11:35

    Session starts at 11:05
    Phosphate  Sensing
    Laurent Beck (Nantes, France)

    12:05

    Session starts at 11:05
    FGF23-Related Hypophosphatemic Diseases: Prospect for New Treatment
    Seiji Fukumoto (Tokushima, Japan)

    11:05 - 12:35 
    Nurses' session 1: NICE & T3
    11:05

    Session starts at 11:05
    T3 replacement – What does the evidence suggest?
    Bijay Vaidya (Exeter, UK)

    11:35

    Session starts at 11:05
    The health care professional & patient consultation - Informed decision making
    Antonia Brooke (Exeter, UK)

    12:05

    Session starts at 11:05
    A Beginners Guide: setting up a Nurse-Led Thyroid Clinic
    Jean Munday (Portsmouth, UK)

    12:40 - 13:25 
    Meet The Expert 1
    12:40

    Session starts at 12:40
    Thyroid disease after immune reconstruction
    Carla Moran (Cambridge, UK)

    12:40 - 13:25 
    Meet The Expert 2
    12:40

    Session starts at 12:40
    Functional imaging of the adrenal

    12:40 - 13:25 
    Meet The Expert 3
    12:40

    Session starts at 12:40
    Update on DSD genetics
    John Achermann (London, UK)

    13:25 - 14:40 
    LUNCH, EXHIBITION & POSTERS
    14:45 - 16:15 
    Oral Communications 4 - Thyroid
    14:45

    Session starts at 14:45
    OC4.1
    A high-throughput yellow fluorescent protein (YFP) cell-based screen identifies autophagy modulators to increase the effectiveness of radioiodine therapy
    Martin Read (Birmingham, United Kingdom)

    15:00

    Session starts at 14:45
    OC4.2
    Reduced Length of Hospital Stay with the use of recombinant TSH compared to Thyroid Hormone Withdrawal –A two centre retrospective study
    Mohammad Sadiq Jeeyavudeen (Aberdeen, United Kingdom)

    15:15

    Session starts at 14:45
    OC4.3
    The disturbed thyroid gland homeostasis in conditions of subacute exposure to thyroid-disrupting chemicals: experimental study in Wistar rats
    Aleksandra Buha (Belgrade, Serbia)

    15:30

    Session starts at 14:45
    OC4.4
    Development of auto-immune thyroid dysfunction in multiple sclerosis patients receiving Alemtuzumab is associated with improved response to treatment
    Alina Sovetkina (London, United Kingdom)

    15:45

    Session starts at 14:45
    OC4.5
    The prevalence of thyroid dysfunction and autoimmunity in women with history of miscarriage or subfertility across the United Kingdom
    Rima Dhillon-Smith (Birmingham, United Kingdom)

    16:00

    Session starts at 14:45
    OC4.6
    Driver events in thyroid cancer recurrence
    Hannah Nieto (Birmingham, United Kingdom)

    14:45 - 16:15 
    Oral Communications 5 - Adrenal and Cardiovascular
    14:45

    Session starts at 14:45
    OC5.1
    Central role for corticosteroid-binding globulin in rat HPA axis sexual dimorphism
    Julia Toews (Vancouver, Canada)

    15:00

    Session starts at 14:45
    OC5.2
    Subclinical alpha-1 antitrypsin deficiency is associated with increased free cortisol fraction in plasma
    Luke D Boyle (Edinburgh, United Kingdom)

    15:15

    Session starts at 14:45
    OC5.3
    Common variants in the gene encoding corticosteroid binding globulin influence cortisol-responsive gene networks in human adipose tissue
    Sean Bankier (Edinburgh, United Kingdom)

    15:30

    Session starts at 14:45
    OC5.4
    Pre-receptor metabolism and signalling of glucocorticoids between macrophages and fibroblasts
    Claire Martin (Birmingham, United Kingdom)

    15:45

    Session starts at 14:45
    OC5.5
    Somatic transmembrane domain mutations of a cell adhesion molecule, CADM1, cause primary aldosteronism by preventing gap junction communication between adrenocortical cells
    Xilin Wu (London, United Kingdom)

    16:00

    Session starts at 14:45
    OC5.6
    SLC35F1, a potential marker for aldosterone producing cell clusters
    Emily Goodchild (London, United Kingdom)

    14:45 - 16:15 
    Oral Communications 6 - Reproductive Endocrinology and Biology
    14:45

    Session starts at 14:45
    OC6.1
    Effect of MVT-602, a potent kisspeptin receptor agonist, on LH levels in healthy pre-menopausal women undergoing a minimal controlled ovarian stimulation protocol
    Ali Abbara (London, United Kingdom)

    15:00

    Session starts at 14:45
    OC6.2
    Differential follicle stimulating hormone glycosylation modulates follicle growth and survival rates
    Gillian Johnson (London, United Kingdom)

    15:15

    Session starts at 14:45
    OC6.3
    Investigating the impact of altered maternal extracellular vesicle miRNAs on placental function in women with gestational diabetes complicated by large for gestational age infants
    Kate Timms (Leeds, United Kingdom)

    15:30

    Session starts at 14:45
    OC6.4
    Kallmann syndrome-associated WDR11 regulates primordial germ cell development
    Soo Hyun Kim (London, United Kingdom)

    15:45

    Session starts at 14:45
    OC6.5
    Placental expression of estrogen related receptor γ (ERRγ) is hypoxia-sensitive and is altered in pregnancies complicated by fetal growth restriction
    Zhiyong Zou (Manchester, United Kingdom)

    16:00

    Session starts at 14:45
    OC6.6
    Kisspeptin Enhances the Brain Processing of Attraction in Men
    Lisa Yang (London, United Kingdom)

    14:45 - 16:15 
    Nurses' session 2: Management of Hyper & Hypocalcaemia
    14:45

    Session starts at 14:45
    Aetiology of hyper and hypocalcaemia

    15:15

    Session starts at 14:45
    Patient management of hypercalcaemia & when should the surgeon intervene?
    Neil Gittoes (Birmingham, UK)

    15:45

    Session starts at 14:45
    Patient management of hypocalcaemia & the patient perspective
    Jeremy Turner (Norwich, UK)

    16:15 - 16:45 
    TEA & COFFEE
    16:45 - 18:15 
    Early Careers Symposium: Engaging with the public
    Why stepping out of the ivory tower widens more than just your world
    16:45

    Session starts at 16:45
    How your Society can help you engage the public
    Maralyn Druce (London, UK)

    17:03

    Session starts at 16:45
    Making the best of what you’re given – public engagement grants

    17:21

    Session starts at 16:45
    How to reach out across social media
    Helen Simpson (London, UK)

    17:39

    Session starts at 16:45
    Meaningful engagement with patients: The importance of recognising common humanity in patients is key to improving relationships’

    17:57

    Session starts at 16:45
    Endocrinology in the public eye
    Giles Yeo (Cambridge, UK)

    16:45 - 18:15 
    How do I…2
    16:45

    Session starts at 16:45
    How do I diagnose cyclical Cushing's
    John Newell-Price (Sheffield, UK)

    17:00

    Session starts at 16:45
    How should I manage non-standard thyroid hormone replacement
    Peter Taylor (Cardiff, UK)

    17:15

    Session starts at 16:45
    When and how should I start screening for MEN1 in children
    Liz Crowne (Bristol, UK)

    17:30

    Session starts at 16:45
    How do I decide when to initiate dopamine agonist withdrawal
    Niki Karavitaki (Birmingham, UK)

    17:45

    Session starts at 16:45
    How do I… manage therapeutic glucocorticoid withdrawal
    Claire Higham (Manchester, UK)

    18:00

    Session starts at 16:45
    How do I manage withdrawal of denosumab
    Rachel Crowley (Dublin, Ireland)

    16:45 - 18:15 
    Senior Endocrinologists' Session
    16:45

    Session starts at 16:45
    What happened to the adrenal X-zone?
    Malcolm Peaker (Ayr, UK)

    17:15

    Session starts at 16:45
    Is the estrogenic component of Premarin all bad?
    Richard Santen (Virginia, USA)

    17:45

    Session starts at 16:45
    Potential benefits of better vitamin D status for non-bony disorders?
    Barbara Boucher (London, UK)

    18:20 - 18:50 
    Plenary 6: Society for Endocrinology European Medal Lecture
    18:20

    Session starts at 18:20
    Mechanisms and consequences of endocrine autonomy – lessons learned from the adrenal cortex
    Felix Beuschlein (Zürich, Switzerland)